Document is current
Any future updates will be listed below
-
Authors
Granholm, Anders
Kaas-Hansen, Benjamin Skov
Lange, Theis
Munch, Marie Warrer
Harhay, Michael O.
Zampieri, Fernando G.
Perner, Anders
Møller, Morten Hylander
Jensen, Aksel Karl Georg
-
Funding
Funding for this research was provided by:
Sygeforsikringen "danmark"
Novo Nordisk Foundation
The Research Council at Rigshospitalet
Royal Library, Copenhagen University Library
- License Information
-
More Information
Article History
Received: 15 February 2023
Accepted: 3 June 2023
First Online: 14 June 2023
Declarations
:
: The COVID STEROID 2 trial was approved by the Committees on Health Research Ethics in the Capital Region of Denmark (H-20051056) and all additional relevant national/local authorities, conducted in accordance with the Declaration of Helsinki, and all patients or their legal surrogates gave informed consent. Additional details on approvals and the informed consent procedure are available in the primary trial publication [].
: Not applicable.
: The Department of Intensive Care at Copenhagen University Hospital – Rigshospitalet has received funding for other research projects from the Novo Nordisk Foundation, Pfizer, and Fresenius Kabi, and conducted contract research for AM-Pharma.
